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Abstract This article addresses the increasing influence of economic rationalities in global
health over the past 30 years by examining the genealogy of one economic strategy – taxation – that
has become central to international anti-smoking initiatives in the global South. It argues that this
genealogy sits uncomfortably with the usual story about economics and global health, which
reduces the economisation of international health to neoliberal structural adjustment policies
aimed at stabilisation, liberalisation and privatisation and laments their detrimental effect on
health. While not disputing these policies’ importance and damaging impact, the genealogy of
tobacco taxes outlined in this article shows that the economisation of global health is not only
about neoliberal structural adjustment policies but also about sin taxes, market failures and health
economics. By stressing how changes in health like the global South’s epidemiological transition
can impact on economics and how beneficial taxation can be for health, it also shows that the
relation between economics and health is not always unidirectional and detrimental to the latter. In
doing so, the article contributes to the critique of the often mechanical use of neo-liberalism to
explicate change and calls for other stories about the economisation of global health to be told.
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Introduction
Over the past 30 years, economic rationalities have played an increasingly significant role in
international efforts to promote health in the developing world (Thomas and Weber, 2004;
Brown et al, 2006). Perhaps the most striking symbol of this transformation is the way the
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World Bank – an institution where economists and economic rationalities dominate – has
progressively come to replace the World Health Organization (WHO) as the most important
actor in the field of international health (Abbasi, 1999). But there are many other signs of
economics’ growing influence on global health. Graduates in economics, for example, have
become a familiar presence among organisations active in the field of health in the global
South. There are also a growing number of books, articles and reports that examine different
economic aspects of health care and health services in developing countries. Similarly,
economic concepts like ‘efficiency’ and ‘price elasticity’ as well as economic techniques like
cost-benefit analyses and demand curbs modelling inform an ever-rising number of
international health initiatives funded by philanthropies and development agencies.
The present article addresses this economisation of global health through the examination
of one economic strategy – taxation – that has become central to most existing international
initiatives purporting to curb tobacco consumption in developing countries. Taking a
genealogical approach (Rabinow, 1989; Foucault, 2004; Reubi, 2010), the article identifies
and traces the articulation of the intellectual concepts, expert networks, political the-
ories and techniques that have made taxation so critical in global tobacco control today.
Specifically, it argues that three developments in particular have made it possible for
taxation to become central to current anti-smoking policies and interventions in the global
South: (1) the elaboration of a new body of knowledge on tobacco taxes by North American
and European health economists from the early 1970s onwards; (2) the problematisation of
the tobacco epidemic and, more broadly, non-communicable diseases (NCDs) in developing
countries from the late 1970s onwards; and (3) the active promotion of tobacco taxes by a
network of epidemiologists and economists centred around the World Bank at the turn of the
twenty-first century.
As the article further shows, this genealogy of tobacco taxes sits uncomfortably with the usual
story about economics and global health found in the literature (for example, Whitehead et al,
2001; Thomas and Weber, 2004; Rowden, 2009). This story equates the economisation of
global health with the structural adjustment policies aimed at stabilisation, liberalisation and
privatisation that became dominant in international development in the early 1980s. These
policies, the story goes on, are the product of a longstanding neoliberal critique of development
economics and have, through the way they transformed the organisation and financing of health
care, been extremely detrimental to health in the global South. The genealogy presented in this
article does not dispute that neo-liberal structural adjustment policies have played a critical and
often damaging role in international health over the past 30 years. But, contributing to a
growing literature that questions the way neo-liberalism is mechanically used to make sense of
change (for example, Ferguson, 2009; Collier, 2011), it challenges some of the limitations
inherent to the standard story about economics and global health. In particular, it shows that the
economisation of global health is not only about the neoliberal critique of development
economics and structural adjustment policies but also about health economics, rational
addiction theory, market failures and sin taxes. Furthermore, by stressing both how changes in
health like the global South’s epidemiological transition have influenced economics and how
beneficial tobacco taxation can be for health, it also shows that the relation between economics
and health is not always unidirectional and detrimental to the latter.
Before tracing the genealogy of tobacco taxes and showing how it jars with the
standard story on the economisation of global health, the article describes the key role
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that taxation plays in international efforts to curb tobacco consumption in developing
countries today.
Taxation and Global Tobacco Control
Over the past 10 years, taxation has become the most important tool in international efforts
to curb tobacco consumption in the global South. As the WHO (2009, p. 56) explains in one
of its latest Annual Report on the Global Tobacco Epidemic:
Increasing the price of tobacco products through significant tax increases is the single
most effective way to decrease tobacco use.
Similarly, the Framework Convention Alliance (2012) – probably the world’s largest anti-
smoking advocacy group today – argues that:
Increasing the price of tobacco products [through taxation] is one of the most effective
tobacco control measures available.
The important role played by taxation is also visible in the amount of financial support it
receives from international tobacco control initiatives run by philanthropies and development
agencies located in the global North. For example, the Canadian International Development
and Research Council (IDRC) – one of the first development agencies to fund programmes on
tobacco control in the global South through its Research on International Tobacco Control
Initiative – has regularly funded projects on taxation in countries like South Africa, China,
Mexico and Tanzania (IDRC, 2012). Another illustration is the Rockefeller Foundation’s
2000–2004 Trading Tobacco for Health Initiative, the first substantial grant for global
tobacco control to come from the philanthropic sector, which funded a team of American
economists led by Frank Chaloupka to develop effective tobacco taxation policies in South-
East Asia (Rockefeller Foundation, 2001, p. 84; Rockefeller Foundation, 2003, p. 47).
Similarly, the International Tobacco and Health Research and Capacity Building Program run
by the National Institutes of Health’s Fogarty International Centre has financed American
economists like Tei-Wei Hu to build a knowledge base for tobacco tax policies in Indonesia
and China (Fogarty International Centre, 2012). More recently, both Bloomberg Philan-
thropies and the Gates Foundation have identified taxation as a priority among the
interventions to curb the smoking epidemic in the developing world for which they give
financial support (Frieden and Bloomberg, 2007, p. 1759; Gates Foundation, 2009, p. 1).
A further sign of the importance of taxation for global tobacco control today is the large
body of knowledge on tobacco taxes in developing countries contained in public health
textbooks, health economics journals, reports to funders and manuals. A key element in this
body of knowledge is the medical, political and philosophical arguments in favour of using
taxation in the global South. These arguments comprise: the possibility to reduce the high
mortality rates associated with smoking; the ability to decrease the medical costs and lost
days of productivity due to tobacco consumption; and the fact that the tobacco market does
not work because of information failure and negative externalities (for example, Guindon
et al, 2003; Ross and Chaloupka, 2006; Chaloupka et al, 2011). Another important element
in this body of knowledge is the models, methods and techniques to set up a taxation system,
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including: tax models; methods to determine efficient tax rates; econometric procedures to
forecast tax revenues; physical controls and stamps; systems of registration and licensing;
and techniques to calculate compliance rates (for example, Yurekli and De Beyer, 2004;
Van Walbeck, 2010; WHO, 2010; International Agency for Research on Cancer, 2011).
A further, critical element in this body of knowledge is the analyses of existing tobacco tax
policies in developing countries like China, India, Mexico and Russia. They comprise: an
outline of the national tobacco market, from the regulatory environment and the structure of
the tobacco industry to the consumers’ income levels, values and tastes; a description of the
country’s tax policy; and an estimate of the price elasticity of cigarettes (for example,
Sarntisart, 2003; Ross and Przewozniak, 2004; Tsai et al, 2005; Jimenez-Ruiz et al, 2008;
John et al, 2010).
Another, final indication of the vital role taxes play in international tobacco control today
is the increasing number of economics graduates with some competence in econometric
analysis working on taxation. One can find them not only in economics departments and
schools of public health in the global North but also, thanks to the capacity building efforts
of the IDRC, the Rockefeller Foundation and the Fogarty International Centre, in the global
South. One can also increasingly find them working directly for organisations active in
international tobacco control. One example is the Tobacco Free Initiative (TFI), the WHO
unit in charge of tobacco control, which spearheaded the negotiations that lead to the
adoption of the Framework Convention on Tobacco Control (FCTC), and one of the five
current key partners of the Bloomberg Initiative to Reduce Tobacco Use (BI). Since the mid
2000s, TFI has employed a team of economists led by Aida Yurekli to offer technical support
on tobacco taxation to WHO member states. This technical support has included running
workshops for the personnel of finance ministries and the publication of the 2010 WHO
Technical Manual on Tobacco Tax Administration. Another example is the American
Cancer Society (ACS) – an NGO that has long been key to international efforts to curb the
tobacco epidemic in the global South. A few years ago, ACS hired an international team of
economists directed by Hana Ross. An important part of their work has been to analyse
tobacco tax policies in different developing countries for the BI and to offer technical
support to the Southeast Asian Tobacco Tax Initiative funded by the Gates Foundation.
The Economics of Tobacco and Taxation
The first development that was critical in making taxation an essential tool of current
international anti-smoking efforts is the elaboration of a new body of knowledge on tobacco
taxes by North American and European health economists from the 1970s onwards. As this
section shows, this knowledge transformed the way taxation was conceptualised among
public health and tobacco control experts.
The field of health economics emerged and progressively established itself between the
1960s and the 1980s, first in the USA and the United Kingdom and later in other European
countries (Colvin, 1985, chapter 1; Fuchs 1987; Ashmore et al, 1989, chapter 1; Fuchs, 1996;
Croxson, 1998). Over this period, the proponents of this new academic field – Anthony
Culyer; Alan Enthoven; Rashi Fein; Martin Feldstein; Victor Fuchs; Michael Grossman;
Herbert Klarman; Willard Manning; John Newhouse; Dorothy Rice; Frank Sloan; Kenneth
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Warner; Burton Weisbrod; and others – articulated a large body of economic expertise on
health and health care. Working in public health schools, economics departments and
government agencies, these economists also established research centres (for example, the
National Bureau of Economics Research’s (NBER) Health Economics Programme; the
University of York’s Centre for Health Economics) and research groups (for example
RAND’s Health Insurance Experiment; the UK-based Health Economists’ Study Group),
launched academic journals (for example, Journal of Health Economics;Health Economics),
worked as consultants for governments and businesses and ran MSc and PhD programmes.
The making of this assemblage of expertise, institutions and activities was closely associa-
ted with one of the most important economic trends in the postwar industrialised nations of
North America and Europe: the sharp increase of health expenditures in relation to the gross
domestic product (GDP) (Colvin, 1985, chapter 6; Fuchs, 1996; Croxson, 1998; Fuchs,
2012a). In the USA, for example, where this trend was the most marked, health expenditures
grew from about 4 per cent of GDP in 1945 to about 13 per cent in 1990 (Fuchs, 2012a).
There were different reasons for this sharp increase in health expenditures. First, there was
an important rise in the overall cost of health care due to changing patterns of medical
practice, new technologies and third-party payments associated with the development of
medical insurance (Gordon, 2003, chapter 1). Second, there was a growing amount of public
money spent on social insurance schemes like the National Health Service in the United
Kingdom and both Medicare and Medicaid in the USA, which were created as part of the
dominant, postwar welfarist agenda in order extend health-care coverage to at least the most
vulnerable in the population (Ashmore et al, 1989, chapter 1; Croxson, 1998; Gordon,
2003, chapter 1). Third, there was a rising number of private health-care plans that were set
up, often by large companies for the benefit of their employees (Gordon, 2003, chapter 1;
Fuchs, 2012b). The growing public anxiety and debates generated by the sharp increase in
health expenditures could not fail to arouse the curiosity of economists and provided those
of them willing to work in this area with a multitude of opportunities, from government
positions to consultancies and research grants (Colvin, 1985, chapter 6; Porter, 1995,
chapter 7; Croxson, 1998; Fourcade, 2009, pp. 109–112; Grossman, 2012; Warner, 2012).
The expertise developed by health economists brought new ways to think about,
problematise and investigate health. Steeped in the neo-classical economic tradition
predominant at the time, this expertise was free of any overriding political agenda, mostly
applied and rather hybrid (Culyer et al, 1977; Fuchs, 1987; Morgan and Rutherford, 1998).
Many of the economists who started working on health in the 1960s and 1970s came from
the field of industrial organisation (for example, Klarman, 1965; Ginzberg and Ostow,
1969; Fuchs, 1972; Feldstein, 1979). They were interested in what they called ‘the health-
care industry’ – a service industry centred on physicians, hospitals and public health. Often
with a view to improve efficiency, their research explored different aspects of this industry,
including: the factors like income, price and tastes impacting on the demand for health care;
the characteristics and supply of health manpower like doctors and nurses; and the
organisation and functioning of production units like hospitals. Some of the first economists
to work on health also came from the field of public policy economics (for example, Fein,
1958; Weisbrod, 1961; Rice, 1966; Feldstein, 1967). Escalating government expenditures in
the postwar era, which were due to the state’s increasing involvement in a number of areas
from the construction of roads to the provision of health, rapidly led to questions about
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how best to allocate these growing public resources. Public policy economists were very
successful in responding to this demand, offering policymakers ‘scientifically defensible’
studies and procedures ‘to aid [them] make rational choices among alternative projects’
(Weisbrod, 1961, p. xviii; cf. also: Porter, 1995, chapter 7; Fourcade, 2009, pp. 109–112).
In the field of health, these included calculations of the costs of diseases to the economy and
cost-benefit analyses of public health interventions. Yet another, smaller group of early
health economists came from labour economics and human capital theory (for example,
Mushkin, 1962; Grossman, 1972). Focusing on health rather than health care, their some-
what more theoretical work examined how individuals invested in their own health through
a range of actions from purchasing medicines to eating well and how this investment was
dependent on factors like age, education and income.
Interestingly, most of the economists working in these new areas of research were keen
to emphasise that health and health care were ‘special’ and did not always easily lend
themselves to standard neo-classical economic approaches (Colvin, 1985, chapter 6).
In other words, health and health care had unique characteristics that jarred with some
of the concepts and models customarily used by economists and necessitated other kinds
of methods and treatments. As Kenneth Arrow (1963, p. 948) explained in his seminal
article on Uncertainty and the Welfare Economics of Medical Care: health has ‘special
characteristics’ that ‘distinguish it from the usual commodity of economics textbooks’ and
‘establish a special place for [it] in economic analysis’. Perhaps the most remarkable issue for
these economists was the way health and health care did not sit well with many of the
assumptions that underlay the notion of the competitive market (for example, Arrow, 1963;
Klarman, 1965; Feldstein, 1967; Culyer, 1971; Fuchs, 1972). To start with, the unpredic-
table incidence of illness meant that, in contrast to other commodities like food or clothing,
the demand for health care was irregular and uncertain, making it difficult for patients
to plan and calculate potential costs. Similarly, consumer rationality was deemed to be
jeopardised by the fact that patients generally lacked the necessary information about their
illnesses and had to rely on doctors for advice that should be completely divorced from any
profit motive. Furthermore, individual choices about health were often held to generate
positive or negative externalities for other members of society, as with decisions to purchase
immunisations against infectious diseases. Most health economists thought that these
uncertainties, information deficits and externalities caused market failures that had to be
corrected through government interventions.
Tobacco as an economic issue
From the 1970s onwards, as smoking was becoming a major public health issue in North
America and Europe, some health economists started to apply the questions, concepts and
methods that they had developed in relation to health and health care to tobacco (Berridge,
2007; Brandt, 2007). By the 1990s, these economists had produced an extensive body of
knowledge on smoking and health, which soon became known as ‘the economics of tobacco’
(Chaloupka and Warner, 2000). An important part of this knowledge was the studies that
sought to determine the economic costs of smoking to the national economy (for example,
Luce and Schweitzer, 1978; Leu and Schaub, 1984; Warner et al, 1999). Building on previous
work done by health economists on the costs of diseases, these studies were often marred by
controversies as to what costs should be included in the calculations. Another important part
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of tobacco economics, which is more relevant to us, was the analyses on the effectiveness of
tobacco control measures like health campaigns, advertising bans and sin taxes – as excise
taxes on cigarettes were often referred to (for example, Atkinson and Townsend, 1977;
Warner, 1977; Lewit and Coate, 1982; Manning et al, 1989). Drawing on earlier health
economics research on both the cost-effectiveness of health interventions and the demand for
health, these analyses sought to determine how efficient these different tobacco control
measures were by measuring their impact on the demand for cigarettes.
The first health economists to carry out extensive work on tobacco taxation were Joy
Townsend at the British Medical Research Council, Kenneth Warner at the University of
Michigan’s School of Public Health, and Michael Grossman with some of his colleagues at the
NBER Health Economics Programme like Eugene Lewit, Douglas Coate and, later on, Frank
Chaloupka. Others joined from the late 1980s onwards, as efforts against smoking intensified
and funding for research on tobacco control, like that from the Robert Wood Johnson
Foundation in the USA, increased. They included: Willard Manning, Jeffrey Wasserman and
others at RAND; Robert Leu at the University of Bern, Switzerland; Tei-Wei Hu at the
University of California, Berkeley; andMarkku Pekurinen at the Finnish National Public Health
Institute. For the majority of these economists, the primary reason for working on taxation was
to further develop and improve public health and tobacco control policy. Indeed, most of them
shared the concerns of the anti-smoking movement and often actively supported it. Townsend,
for example, who started working on taxation in the early 1970s, became increasingly active in
the international tobacco control movement, regularly attending the World Conferences on
Tobacco or Health and working as an expert for the WHO’s first European Action Plan on
Tobacco (for example, Atkinson and Townsend, 1977; Townsend, 1988; Townsend, 1996; cf.
also Berridge, 2007, pp. 129–131). Similarly, Warner, who began writing on taxation in the
early 1980s, was closely associated with anti-smoking efforts both in the USA and
internationally (for example, Warner, 1984b; Warner, 1986; Warner, 1990; Warner, 2012).
However, for a small minority of these health economists the reasons for working on
tobacco taxes were slightly different. The best example is probably Grossman, who carried
out research on taxation from the late 1970s onwards, and Chaloupka, who began working
on the topic as Grossman’s PhD student in the late 1980s (for example, Lewit et al, 1981;
Grossman, 1985; Chaloupka and Grossman, 1996; Chaloupka and Wechsler, 1997). While
they were interested in the policy dimensions of their research and not unsympathetic to the
concerns of the anti-smoking movement, they also saw their work as contributing to the
economics of addiction (Chaloupka, 2012; Grossman, 2012). Specifically, they saw their
work as feeding into a collaborative effort with Chicago School economist and neoliberal
thinker Gary Becker – with whom Grossman had completed his doctoral thesis on human
capital and health in the late 1960s – to develop and test his theoretical model of rational
addiction (for example, Becker and Murphy, 1988; Chaloupka, 1991; Becker et al,
1994). For Becker, the consumption of addictive goods – defined as goods for which past
consumption stimulates and reinforces current consumption – was a rational behaviour
that could be explained by rational choice theory. Consequently, his model conceived the
consumption of addictive goods like alcohol, tobacco and cocaine as a rational choice made by
utility-maximising individuals on the basis of their income, prices and the risk of becoming
dependent. This work on addiction was part of Becker’s imperialist agenda to apply economic
methodologies to issues commonly thought to be the domain of sociologists, psychologists and
Health economists, tobacco control and international development
211r 2013 Macmillan Publishers Ltd. 1745-8552 BioSocieties Vol. 8, 2, 205–228
political scientists such as education, racial discrimination, crime, marriage and organ donation
(Foucault, 2004; Medema, 2011). It was also related to Becker’s conviction that the war on
drugs had failed and his campaign for a new approach to drugs, namely: the legalisation of
drugs combined with a high sin tax on consumption, restrictions on selling to minors, public
education about the dangers of drugs and severe punishment for those driving or working while
on drugs (Becker, 1997; Becker, 2001; Thornton, 2005).
By the late 1980s, research on tobacco taxation had started to coalesce into a coherent and
stable body of work. A key finding was the ascertainment that price was a critical factor in
reducing demand for tobacco products and that increasing taxes was one of the most
powerful measures to combat smoking (Atkinson and Townsend, 1977; Lewit et al, 1981;
Warner, 1986; Chaloupka and Grossman, 1996; Townsend, 1996). This research did not just
determine the effectiveness of tobacco taxes but also examined in detail how they worked.
To start with, it measured the price elasticity of tobacco products, estimating it to be around
minus 0.5 (Lewit and Coate, 1982; Pekurinen, 1989; Townsend, 1993). This means ‘that, on
average, cigarette consumption reduces about 0.5 per cent for every 1 per cent increase in its
real price’ (Townsend, 1996, p. 132). This research also eventually made clear that about
half of the impact of price on cigarette consumption results in equal measure from its effect
on smoking prevalence and smoking intensity (Chaloupka et al, 2012). Moreover, it showed
that the impact of tax increases is more marked for young adults and for members of low
socio-economic groups, for whom the effects of public information and education
programmes are least effective (Lewit et al, 1981; Townsend, 1987). Furthermore, this
research determined the type and rate of tax needed to decrease smoking prevalence by a
given amount and drew attention to the fact that inflation will erode the impact of taxes
unless these are increased accordingly (Townsend, 1993). Finally, it also made clear that a
tax rise does not only improve a country’s health but also its finances, as the tax rise largely
compensates for the decrease in cigarette consumption (Warner, 1984b).
It is interesting to note that many health economists working on tobacco taxation were
concerned with whether or not a government intervention like taxation was justifiable in
economic terms. Not unlike the argument that had been made about health and health care,
they claimed that the market failed to work efficiently in relation to tobacco and that
governments had therefore to intervene through taxation and other public health measures
(for example, Atkinson and Townsend, 1977; Lewit et al, 1981; Leu and Schaub, 1984;
Manning et al, 1989; Pekurinen, 1992). Even a free market enthusiast like Gary Becker was
happy to acknowledge market failure in relation to tobacco and to sanction a tax on tobacco
products, which he saw as a ‘social tax’ whose purpose was to correct the ‘social costs’
associated with smoking (Becker, 1997, p. 150; cf. also: Becker, 2001; Becker, 2012). While
most economists agreed that there was market failure in relation to smoking, they disagreed
about the exact reasons for this failure. All, including Becker, concurred that one important
reason was that, contrary to the tenets of neo-classical economic theory, consumers did not
make informed choices in relation to smoking and did not bear all the costs of their choices.
Indeed, as these economists pointed out: smokers were not fully aware of the high risks
in terms of both health and addiction; and they imposed negative externalities onto
non-smokers through passive smoking and running medical bills that were covered by social
insurance schemes (Chaloupka, 2012; Warner, 2012). Many economists also argued that
another reason for market failure was addiction itself, which made it impossible for smokers
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to take rational decisions – a point contested by researchers like Grossman, Chaloupka and
Becker for whom the consumption of addictive goods was a rational behaviour (for example,
Atkinson and Townsend, 1977; Leu and Schaub, 1984; Manning et al, 1989).
This knowledge on tobacco and taxes produced by economists helped to markedly
transform the way taxation was perceived by the public health community. Public health
experts had identified taxation as a possible smoking control measure in the 1970s already
(Fletcher et al, 1971, p. 453; WHO, 1975, pp. 25 and 81–82; WHO, 1979, pp. 32 and
58–60; Roemer, 1982, pp. 73–75). But, until the 1990s, it remained extremely unpopular among
the public health community who generally ignored it (Scott and Dickert, 1993; Warner,
2012). At best, public health experts considered taxation to be a minor and complementary
measure that could be used to support and augment public information and education
campaigns, which were the preferred tobacco control strategies at the time (WHO, 1975, pp.
23–24; WHO, 1979, pp. 45–53; Roemer, 1982, pp. 73–75). The reasons for this perception
of taxation were multiple. First, taxation was tainted by its association with economists who
were often viewed with suspicion and even hostility by public health activists (Fuchs, 1996;
Croxson, 1998). Second, most public health experts did not really understand how taxation
worked or whether it worked at all, with many believing that price had no impact on addicts
(for example, Fletcher et al, 1971, p. 453; WHO, 1975, pp. 31–32; WHO, 1979, p. 59;
Roemer, 1982, pp. 73–75). Third, many in the public health community were uneasy about
the regressive nature of tobacco taxes, which meant that they hit the poor the hardest (Scott
and Dickert, 1993; Chaloupka et al, 2012). Fourth, several public health advocates thought
it was ‘reprehensible’ to try and ‘change people’s behaviour by using an extrinsic motivator
like price rather than an intrinsic one like being concerned about one’s health’ (Warner,
2012). The research done by health economists was critical in transforming the perception of
taxation among the public health community from a tobacco control policy that was
unpopular and ignored to one that has become viewed as the most powerful measure to curb
smoking (Scott and Dickert, 1993). As Kenneth Warner (2012), one of the first economists
to work on tobacco taxes, makes clear:
There has been a complete change in the way the public health community perceives
tobacco taxes y . In the early 1980s public health experts had an incredibly strong
negative reaction towards taxesy . Now, taxes are viewed as the key tobacco control
strategyy . The work of economists was critical in bringing this change.
Tobacco and the Developing World
The second development that made it possible for taxation to become a critical tool of
current international efforts to curb smoking in the global South was the problematisation of
tobacco in developing countries. As this section shows, the realisation that smoking was
becoming an important problem in the developing world led public health experts to suggest
taxation as a possible solution and to call for economic research on taxation in the global
South.
For a long time, tobacco was considered to be an issue that was exclusive to the rich,
industrialised nations in the North (Brandt, 2007, chapter 9). Indeed, few public health
Health economists, tobacco control and international development
213r 2013 Macmillan Publishers Ltd. 1745-8552 BioSocieties Vol. 8, 2, 205–228
experts imagined that tobacco could be a problem for developing countries. For them,
developing countries were beset by infectious diseases, malnutrition and poverty; not NCDs
and contributing risk factors like smoking. From the late 1970s onwards, this understanding
progressively changed and tobacco became recognised as a problem for countries in the
global South. An important moment in this process was the publication of Mike Muller’s
1978 Tobacco and the Third World and Bo Wickerstro¨m’s 1979 Cigarette Marketing in the
Third World. Written by development experts, these two publications made it clear that a
tobacco epidemic was on its way in the global South. They did so by showing how Western
tobacco companies were hard at work creating new markets in Latin America, Asia and
Africa through the setting up of efficient distribution systems, aggressive marketing
strategies and intense lobbying of governing elites. They also showed how these companies
were successfully pushing farmers in the developing world to cultivate tobacco in lieu of
food crops. This, they argued, was causing increased poverty, higher mortality and
morbidity, desertification and food shortages. Public health experts were quick to pick up on
Muller and Wickerstrom’s work and begin identifying smoking as a problem for developing
countries (Ramstro¨m, 1985). A significant event in that respect was the publication in 1983
of Smoking Control Strategies in Developing Countries, a report in which the WHO
recognised the rapid spread of a smoking epidemic in developing countries and suggested
measures to halt its progress. During the next 15 years, the problem of smoking in the
developing world would become increasingly acknowledged, studied and discussed
in official reports, scholarly texts and at conferences (for example, Crofton, 1984; Chapman
et al, 1986; Surgeon General, 1992; Bellagio Statement, 1995).
The way in which the problem of tobacco in the developing world was portrayed varied
little throughout the 1980–1990s. First, as Muller and Wickerstro¨m had showed, the smoking
epidemic in the global South was deemed to be due to ruthless transnational tobacco
corporations searching for new markets (for example, WHO, 1983, pp. 8–9; Stebbins, 1990,
p. 229; Mackay, 1991, p. 153). Second, the rise in smoking and smoking-related diseases in
developing countries was understood to be part of a wider ‘epidemiological transition’ taking
place in those countries at that time: the increase in NCDs and their growing impact on
mortality and morbidity rates (Jamison et al, 1984; Feachem et al, 1992; Jamison et al, 1993).
Third, the increase of tobacco-related diseases in developing countries was thought to be
particularly disastrous because of the additional medical and financial burden it created for
these countries that, unlike the rich industrialised nations of the North, were still struggling
with infectious diseases and malnutrition (for example, WHO, 1983, p. 9; Crofton, 1984,
p. 270; Chapman et al, 1994, pp. 189–190). Fourth and finally, the rise of smoking and
smoking-related diseases in the developing world was often seen as a harmful, unintended side
effect of the industrialisation and modernisation process, which developing countries had to go
through (for example, Warner, 1984a, p. 37; Stebbins, 1990, p. 228).
Although the way the problem of tobacco in the global South was portrayed varied
little during the 1980–1990s, the manner in which it was measured became increasingly
sophisticated. For most of the 1980s, the evidence for the growing numbers of smokers and
smoking-related diseases in the developing world was ‘patchy’: reports from doctors work-
ing in the field and a few small hospital and community surveys (Crofton, 1984, p. 269;
Chapman et al, 1994, p. 189; Vateesatokit, 2003, p. 161). More rigorous and sophisticated
evidence began appearing from the late 1980s. To start with, a growing number of
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developing countries started conducting regular national surveys to assess smoking rates.
There was also a multiplication of epidemiological studies on smoking-related mortality and
morbidity in the global South. Finally, there was the work of Richard Peto, Alan Lopez and
their colleagues at the WHO that purported to produce credible estimates for worldwide
smoking-related morbidity and mortality (for example, Peto et al, 1994; Peto et al, 1996). This
increasingly sophisticated epidemiological evidence certainly strengthen public health experts’
conviction that tobacco had become a problem for the global South.
The realisation that smoking was becoming an important problem in the developing world
led public health experts to suggest possible solutions. These solutions included: a whole
array of policies and measures to combat the epidemic (for example, Roemer, 1982; WHO,
1983; World Bank, 1993b); workshops run by organisations like the International Union
against Cancer to build up tobacco control advocacy networks in developing countries
(Wood, 1994); and calls for research to understand the specificities of the smoking epidemic
in the global South (for example, Surgeon General, 1992, p. 10; Bellagio Statement, 1995,
p. 1110). Importantly for us, taxation was one of the policies and measures suggested by
public health experts to tackle the smoking epidemic in the developing world. This is not all
that surprising given that these policies and measures were generally modelled on those in
existence in the rich, industrialised nations of the North (Brown and Bell, 2008). Nor is it
surprising that, mirroring what had happened in the North, the understanding of tobacco
taxation in the global South shifted from a measure that was unpopular and minor at best
(for example, Roemer, 1982, pp. 73–75; WHO, 1983, pp. 56–58) to one that was essential
(for example, Surgeon General, 1992, pp. 127–136; Roemer, 1993, chapter 8; World Bank,
1993b, p. 2; Chapman et al, 1994, p. 191). Understandably, this shift was accompanied by
calls for research on the specificities of the economics of tobacco and taxation in the global
South (for example, Warner, 1990; Surgeon General, 1992, p. 10).
The World Bank and Tobacco Taxes
The third development that was critical in making taxation into an essential tool of current
international anti-smoking efforts in the developing world was the active promotion of the
Western economic knowledge on tobacco taxation by World Bank economists and
epidemiologists from the late 1990s onwards. While the problematisation of tobacco in
the developing world had led to taxation being suggested as a possible solution, this active
promotion ensured that taxation was effectively disseminated to and used by countries in the
global South.
One of the reasons for the Bank’s critical role in promoting tobacco taxation in the global
South has been its increasing involvement with international health over the last few
decades. The Bank’s initial engagement with health was driven by a change in thinking about
development in the 1970s (Finnemore, 1997; Fair, 2008). Both at the Bank and within the
wider development community, there was a growing recognition that development should be
about poverty alleviation rather than just economic growth. This meant that the Bank had to
complement its usual development strategies aimed at improving countries’ physical capital
(roads, railways, agriculture and so on) with strategies aimed at improving their human capital
like education and health. This newfound interest in health led the Bank to create a new
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department – the Health, Nutrition and Population department (HNP) – and offer loans to
countries for health-related projects (for example, family planning, nutrition programmes and
so on). The Bank’s involvement in international health steadily increased during the 1980–
1990s, so much so that at the end of the century it was lending countries over 2 billion dollars
for health-related projects and had become the world’s premier health institution, pushing the
WHO to the sidelines (Abbasi, 1999). An important part of the Bank’s work on health during
that time was concerned with the epidemiological transition then taking place in developing
countries and how to ease the additional financial burden this generated for these countries’
health systems. The solutions put forward by HNP epidemiologists and economists like Dean
Jamison, Anthony Measham and Richard Feachem were varied (for example, Jamison et al,
1993; World Bank, 1993a). Some involved focusing efforts on high-morbidity and mortality
diseases as well as privileging the most cost-effective health interventions. Others, more
controversially and no doubt influenced by the neo-liberal critique of development economics
that was then becoming predominant, included structural adjustment policies like public
deficit reduction and privatisation strategies (Rowden, 2009).
It is as part of this increasing engagement with health that, in the late 1980s, the Bank first
got involved with tobacco control. Its involvement was twofold. The first instance was the
Bank’s revision of its lending policy for tobacco production. The Bank had long lent money
to countries to develop their tobacco production infrastructure; indeed, as with any other
industry, investment in the tobacco industry was deemed to generate economic growth and
development. With the recognition of tobacco and NCDs as a problem for developing
countries in the 1980s, the Bank’s tobacco lending policies became increasingly criticised. As a
result, following efforts from HNP epidemiologists and economists like Howard Barnum,
Anthony Measham and Ann Hamilton, the Bank stopped lending for tobacco production in
1991 (World Bank, 1992; World Bank, 1993b). The second instance was the use of tobacco
and tobacco control policies by HNP experts in the first edition ofDisease Control Priorities in
Developing Countries (1993). A key conclusion of this publication was that, given the growing
costs associated with NCDs in the global South, governments in developing countries should
concentrate their efforts on cost-effective measures targeting diseases affecting the largest
number of their citizens. Tobacco control policies were deemed to be the perfect illustration of
such measures by Dean Jamison and his colleagues; indeed, they were extremely cost-effective
and tackled one of the future’s biggest causes of mortality and morbidity in the developing
world (Jamison et al, 1993, chapters 1, 2, 21 and 29 and annex A).
Given the Bank’s interest and work not only in economics and development but also in
health and tobacco control, it is not surprising that it actively promoted and disseminated
existing economic knowledge on tobacco taxation to developing countries between 1995
and 2005. An important component of the Bank’s promotion and dissemination efforts
was the publication of both Curbing the Epidemic and Tobacco Control in Developing
Countries (Jha and Chaloupka, 2000). These two publications, which outlined and discussed
the relevance of tobacco economics for the developing world, were written by a team led
by Prabhat Jha, a young and dynamic HNP epidemiologist, and composed of renowned
economists and public health experts, including: Frank Chaloupka, Tei-Wei Hu, Dean
Jamison, Judith Mackay, Markku Pekurinen, Richard Peto, Ruth Roemer, Joy Townsend,
Kenneth Warner and Derek Yach. These two publications did three things in particular. First,
they presented this knowledge in a form that was easily accessible and comprehensible
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to non-economists (World Bank, 1999, pp. 37–45; Jha and Chaloupka, 2000, chapter 10).
Second, they showed the relevance of tobacco taxes for developing countries by explaining
that it was the most cost-effective measure to address the tobacco-related epidemic of
chronic diseases and premature death that was now rapidly affecting the developing world
(World Bank, 1999, chapter 1; Jha and Chaloupka, 2000, chapters 2–4). Third, they also
justified tobacco taxes in economic terms, by explaining that, in the case of tobacco, there
were market failures that necessitated governmental interventions, including taxation
(World Bank, 1999, chapter 3; Jha and Chaloupka, 2000, chapter 7).
The Bank’s efforts to promote and disseminate knowledge on tobacco taxation did not
stop with the release of these two publications but continued until 2005 through a
multiplicity of activities organised by HNP economists Aida Yurekli and Joy de Beyer (World
Bank, 2005). First, the Bank sent representatives to the FCTC negotiations to comment on
economic issues including taxation. Second, the Bank distributed over 17 000 copies of
Curbing the Epidemic in over 20 languages and ran a website dedicated to tobacco
economics. Third, the Bank conducted over 60 seminars and workshops on the economics of
tobacco in general and taxation in particular, which were held in developing countries and
open to governmental officials, public health experts and tobacco control advocates. Fourth,
the Bank drafted and published a manual on how to conduct economics analysis on tobacco
control in developing country – the World Bank Economics of Tobacco Toolkit – with one
whole chapter dedicated to taxation (Yurekli and de Beyer, 2004, Tool 4). Fifth and finally,
the Bank also commissioned research papers and notes on the economics of tobacco and
taxation in over 25 developing countries.
The Bank’s efforts had a remarkable effect. In the decade that preceded the publication of
Curbing the Epidemic in 1999, there had been only three research projects on the impact of
price on tobacco consumption and one attempt to use tobacco taxation as a public health
tool in developing countries: Simon Chapman and his colleagues’ research on the effects of
taxation on cigarette consumption in Papua New Guinea in the late 1980s (Warner, 1990);
Supakorn Buasai and his colleagues’ successful attempt to lobby the Thai government to
increase taxes on cigarettes to reduce smoking prevalence in the mid-1990s (Vateesatokit,
2003, pp. 162–163); Zhengzhong Mao and J.L Xiang’s work on the relation between price
and smoking prevalence in China in the late 1990s (Mao and Xiang, 1997; Mao et al, 1997);
and Iraj Abedian’s Economics of Tobacco Control in South Africa project funded by the
IDRC in the late 1990s (IDRC, 2012). In contrast, in the decade that followed, there have
been countless initiatives, funding schemes and research projects on tobacco tax policies in
the global South, as outlined in great detail in the first section of this article.
The Economisation of Global Health beyond Structural Adjustment
There has been a growing critique of the often superficial and un-reflexive way in which
social scientists have depicted neo-liberalism as a harmful force at the heart of most of the
political and economic transformations that have taken place in the last few decades
(for example, Clarke, 2008; Collier, 2009; Ferguson, 2009; Mirowski and Plehwe, 2009;
Collier, 2011). These authors have pointed out that the omnipresence and omnipotence
attributed to neo-liberalism in these depictions threatens to deprive the concept of any
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analytical value. Indeed, it makes little sense to say that everything – from knowledge and forms
of governance to subjectivities and spaces – is neoliberal or shaped by neo-liberalism. Similarly,
they have argued that these depictions frequently misunderstand neoliberal thought. In
particular, they have showed that: neo-liberalism is often mistakenly equated with other related
yet distinct bodies of knowledge such as neo-classical economics; neo-liberalism is repeatedly
portrayed in ways that are too monolithic and ignore the plurality of thought among and
tensions between the many factions that make up the transnational networks of intellectuals
and think tanks centred around the Mont Pe`lerin Society; and neo-liberalism is regularly
caricatured as when deemed to lack any notion of justice or the social. Likewise, these authors
have contended that most depictions of neo-liberal ideas and practices tend to overlook their
instability and the possibility of them being re-appropriated and transformed over time and
space. Finally, they have also deplored the unexamined belief informing much social science
research that neo-liberalism is necessarily negative and harmful. The genealogy of tobacco taxes
outlined above contributes to this critique by highlighting some of the weaknesses of the
standard story about the economisation of global health found in the social sciences literature.
The standard story
As already alluded to, the usual story about economics and global health equates the
economisation of global health with the structural adjustment policies that have been
predominant in international development over the past 30 years (for example, Whitehead
et al, 2001; Thomas andWeber, 2004; Maciocco, 2008; Rowden, 2009; Schrecker et al, 2010).1
Often referred to as ‘the Washington Consensus’, structural adjustment policies are a set of
policies aimed at stabilisation, liberalisation and privatisation (Mosley et al, 1991, chapter 1;
Williamson, 2004; Rowden, 2009, chapters 6–8; Plehwe, 2009a). They comprise: currency
devaluation; inflation control policies; public deficit reduction strategies; the removal of trade
barriers such as tariffs and quotas; the opening of financial markets to foreign investments; the
abolition of price controls; the deregulation of key industries through the elimination of licen-
sing regimes and other market entry impediments; the softening of labour regulations onminimum
wages, working hours and redundancy; and the privatisation of state-owned enterprises. These
policies began to dominate the field of international development in the early 1980s. Indeed, it was
then that they became a standard lending modality of general budgetary support loans from the
International Monetary Fund and the World Bank, thus forcing developing countries to roll back
the state and introduce free market reforms in exchange for financial support (Mosley et al,
1991, chapter 2; Rowden, 2009, chapter 6; Collier, 2011, chapter 6).
As the usual story on the economisation of health rightly claims, structural adjustment
policies are closely related with neo-liberalism and, more specifically, with the neoliberal critique
of state-centred development economics, which Toye (1987) has called the ‘counter-revolution
in development economics’ (Mosley et al, 1991, chapter 1; Plehwe, 2009b; Collier, 2011,
chapter 6). In the three decades that followed World War II, the field of international develop-
ment was dominated by a statist model. Promoted by economists like Gunnar Myrdal,
Raul Prebisch and Walt Rostow, this model aimed to modernise poor countries through an
accelerated, state-led industrialisation process based on strategies such as: central planning,
1 The attraction for these neoliberal policies has recently begun to wane (Boseley, 2012; Elliott, 2012; Lal,
2012).
Reubi
218 r 2013 Macmillan Publishers Ltd. 1745-8552 BioSocieties Vol. 8, 2, 205–228
infrastructure development, selective subsidies, public ownership, price controls, trade
tariffs and labour regulations. From the 1950s onwards, scholars associated with the Mont
Pe`lerin Society and other neoliberal think tanks like Peter Blau, Herbert Frankel and Deepak
Lal began to articulate a critique of this state-led model (Toye, 2009; Plehwe, 2009b; Collier,
2011, chapter 6). Most generally, they argued that the very division of the world into a
developed and underdeveloped area, with the latter requiring special economic development
measures, was fallacious as the market mechanism was supposed to be the same everywhere
(Strassmann, 1976). They also criticised the infatuation with industrialisation, claiming that it
discriminated against poor farmers in rural settings, and lamented the pessimism about the
promise of international trade to generate growth. More importantly for us perhaps, these
neoliberal critiques had a ‘profound scepticism toward the state, frequently regarded as a self-
interested bureaucracy inclined towards predatory behaviour’, and contended that ‘government
interventions in market processes encouraged rent-seeking dynamics’ and other distortions that
were ‘inimical to productive economic activity and genuine development’ (Bair, 2009, p. 364). To
deliver genuine development, they argued, one needed to correct these distortions by ‘opening up
economic activity to the free play of market forces’ (Mosley et al, 1991, p. 24). In particular, one
needed to roll back the state and embrace both domestic entrepreneurship and international trade as
alternative engines of growth. By the late 1970s, this neoliberal critique had become the dominant
paradigm and was instrumental in shaping structural adjustment policies from the 1980s onwards.
These structural adjustment policies, as the standard story on the economisation of
global health further explains, have had a hugely detrimental effect on health in the global
South (for example, Whitehead et al, 2001; Stuckler et al, 2008; Rowden, 2009; Stuckler
et al, 2009; Schrecker et al, 2010). There is little doubt that structural adjustment policies
have had a major impact on the way medical care and public health is organised, managed
and financed in the developing world (for example, World Bank, 1987; World Bank,
1993a). To start with, public deficit reduction strategies have brought about: salary caps
and lay-offs for doctors and nurses working in the public sector, often causing them to
emigrate in search of better working conditions; the closure of public hospitals and health-
care services; the elimination of public subsidies for any non-essential public health
programmes, medical services and drugs; and the development of alternative sources of
revenue through the establishment of user fees and private insurance schemes (Stuckler
et al, 2008; Rowden, 2009, chapters 9–10). At the same time, privatisation schemes have
led to an increasing number of hospitals and health-care centres being managed along
market principles by private companies and public–private partnerships, thereby making
access to health care difficult for many (Rowden, 2009, chapters 9–10). Likewise,
deregulation policies in the pharmaceutical market have led to an ‘irrational use of
medicines’ caused by the increased ‘sale of drugs without prescription by unqualified
people who have financial incentives to overprescribe’ (Whitehead et al, 2001, p. 834).
Unsurprisingly, these impacts on the organisation, management and financing of health
care brought about by structural adjustment policies have led to a rise in both morbidity
and mortality rates, especially in the countries of the ex-Soviet Union and sub-Saharan
Africa (Whitehead et al, 2001; Stuckler et al, 2009; Schrecker et al, 2010).2
2 However, see the recent critique by Gerry (2012), who argues that the statistical method used to correlate
mass privatisation and higher mortality rates in the ex-Soviet Union is flawed.
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An alternative narrative on economics and global health
The genealogy of tobacco taxes presented in this article does not contest that neo-liberal
structural adjustment policies have been influential in and often detrimental to international
health over the past 30 years. Rather, it challenges some of the limitations inherent to the
standard story outlined above and suggests that it is not the only narrative about economics
and global health that can and should be told.
First of all, this genealogy shows that one cannot reduce the economisation of global
health to neoliberal structural adjustment policies, as the standard story tends to do. Indeed,
tobacco taxes are not a structural adjustment policy aimed at liberalisation, stabilisation and
privatisation, but a public health policy aimed at reducing tobacco consumption and the
growing burden of NCDs associated with it, on a par with indoor smoking bans and anti-
smoking health education. Furthermore, tobacco taxes have a different genealogy than
structural adjustment policies. In particular, they have not been made possible by the
neoliberal counter-revolution in development economics, but by the emergence of health
economics. These are two different projects developed by different people. Articulated by
thinkers associated with the networks centred about the Mont Pe`lerin Society, the neoliberal
critique of development economics was a political project that sought to transform
international development by rolling back the state and embracing free trade and markets. In
contrast, health economics was a hybrid, mostly applied field of research free of any
overriding political agenda where academic economists coming from industrial organisation,
public policy and labour economics sought to empirically explore health-related issues like
the organisation of the health-care industry, the cost-effectiveness of public health
interventions and the demand function for health. Importantly, the genealogy of tobacco
taxes outlined in this article shows that, while certainly not unheard of, the desire to roll
back the state and the enthusiasm for markets that characterised the neoliberal counter-
revolution in development economics had little resonance within health economics.3
If anything, most health economists thought that health was characterised by uncer-
tainties, information failures and externalities that did not necessarily sit well with the
market model and often had to be corrected through government action (Colvin, 1985,
chapter 6). This way of thinking was even more marked for tobacco, with virtually
all health economists concurring that there was market failure in relation to smoking
and a need for government interventions like tobacco taxes (Jha and Chaloupka, 2000,
chapter 7).
It is important to note that the fact that tobacco taxes are not related to the neoliberal
critique of development economics does not mean that there are no connections between
tobacco economics and other, different strands of the neoliberal tradition. As the genealogy
of tobacco taxation presented here shows, the most significant connection between tobacco
3 Of course, some health economists did advocate market solutions in relation to the production and
allocation of health. The work of Michael Cooper and Anthony Culyer, where they argued in favour of
using the price mechanism to organise the supply of blood for transfusions and which they carried out in
the 1960s with the support of the neoliberal Institute of Economic Affairs, is perhaps the best example
(Fontaine, 2002). But that was a minority position as Cooper and Cuyler themselves recognised in their
1973 textbook on Health Economics, in which they explained that the ‘market-versus-state debate’ was
now ‘in the past’ and that ‘the trend’ in health economics was ‘towards empiricism, applying theory to
solve real-world problems rather than engaging in abstract speculation’ (1973, p. 7).
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economics and neoliberalism was the one involving Gary Becker. A professor of economics
at Chicago and an important neoliberal thinker, Becker was not himself a health economist
and did not work directly on tobacco (Plehwe, 2009a; Medema, 2011). But, through his
association with Michael Grossman and Frank Chaloupka, his theory of rational addiction
and his imperialist agenda to apply economic approaches to issues traditionally outside
economics had some influence on tobacco economics (Grossman, 2012). But, this influence
should not be exaggerated and does certainly not warrant calling tobacco economics
‘neoliberal’ in any meaningful sense. Most tobacco economists had no links with Becker and
only very limited interest in his theory of rational addiction; often actively involved in the
anti-smoking movement, their prime concern was to help improve tobacco control policy
through the use of standard, neo-classical economic tools (Warner, 2012). Besides, Becker’s
work on addiction and, more broadly, on the legalisation of drugs had very little to do with
the free market and anti-statist stance commonly associated with neoliberalism. Indeed,
Becker admitted market failure in relation to tobacco, alcohol and drugs and called for
government interventions like sin taxes, something other neoliberal thinkers explicitly
disagreed with (Becker, 1997; Thornton, 2005; Becker, 2012).
It is also important to note that the fact that tobacco taxes are not related to the neoliberal
critique of development economics and its free market agenda does not signify that they are
somehow against or outside the market. Unlike prohibition or state monopolies, taxation is
not an alternative to the market in terms of how to organise the production and exchange
of tobacco (Thornton, 2005; Becker, 2012; cf. also: Davies, 2013). Tobacco taxes do not
abolish the market by forbidding all production and exchange of tobacco products,
as prohibition would do. Nor do tobacco taxes eliminate the market by allowing one single,
state-owned company to control the entire national production, distribution and sale
of tobacco products, as a state monopoly would do. Instead, taxation works in combination
with the market. Indeed, tobacco taxes assume the existence of a functioning market in
tobacco products. But, because of some failures, this market is not working as well as it
could. Tobacco taxes are there to help correct these failures and thus allow the market to
perform more efficiently. As Chaloupka (2012) explains:
The idea is that there is a market that is working at some levely but there are market
failures that keep it from working as efficiently as it could y . Tobacco control
measures like taxes are going to deal with those market failures.
Another weakness of the standard story about the economisation of global health is how it
only focuses on the impact of structural adjustment policies on health and, consequently, the
way it portrays the relation between economics and global health as unidirectional and
harmful to health. As the genealogy of tobacco taxes outlined here shows, the relation
between economics and global health is much more complex than that. Like the standard
story, this genealogy demonstrates how influential economics can be for global health by
describing the way health economists have made price and taxation so critical to the fight
against smoking and thus transformed global tobacco control. But, the genealogy of tobacco
taxes also offers many illustrations of how changes in health can influence economics. One
of these is the way the continuing and marked increase in health expenditures in the rich,
industrialised countries of the North led to the development of the field of health economics
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in the 1960s. Another illustration is how a shift in the epidemiology of disease – the
realisation that tobacco-related diseases and, more generally, NCDs have become a key
health issue for the developing world – made it possible for the economic expertise on
tobacco taxation to be exported to the global South. Moreover, the genealogy of tobacco
taxes outlined in this article also illustrates that economics is not only detrimental to health,
as in the case of structural adjustment policies, but also beneficial to it. Indeed, as health
economists have demonstrated, an economic strategy like tobacco taxation has an extremely
positive impact on health: first, by markedly bringing down smoking prevalence and
intensity; and, second, by generating increased revenues that can be reinvested in public
health campaigns and other measures (Warner, 1984b; Townsend, 1996; Chaloupka and
Warner, 2000).
Conclusion
The present article explored the recent and extensive economisation of global health through
a close analysis of one economic strategy – taxation – that has become central to
international efforts to curb smoking in developing countries. Adopting a genealogical
approach, it argued that three developments in particular made it possible for taxation to
become so critical to global tobacco control today. The first of these developments was the
articulation, by health economists in North America and Europe in the 1970–1990s, of a
body of knowledge that transformed public health thinking about smoking by showing the
marked impact of price on the demand for tobacco products. The second development was
the problematisation of smoking in the global South from the late 1970s onwards, which
made it possible for public health experts to suggest taxation as a solution to curb the
tobacco epidemic in developing countries. The third development was the active promotion
of tobacco taxes by World Bank epidemiologists and economists at the turn of the twenty-
first century that allowed this strategy to be effectively used in the developing world.
As the article also showed, this genealogy does not sit comfortably with the standard story
on economics and global health found in the social science literature (for example, Thomas
and Weber, 2004; Stuckler et al, 2008; Rowden, 2009). This story reduces the economisation
of global health to the structural adjustment policies aimed at stabilisation, liberalisation
and privatisation that have been dominant in international development over the past 30
years. It also argues that these policies, which were the product of the neoliberal counter-
revolution in development economics, have been extremely detrimental to health in the global
South. The genealogy of tobacco taxation presented in this article did not dispute that neo-
liberal structural adjustment policies have played a significant and damaging role in inter-
national health over the past 30 years. But, it challenged some of the limitations inherent to the
standard story about economics and global health. First, it showed that the economisation
of global health is not only about the neoliberal critique of development economics and
structural adjustment policies but also about health economics, sin taxes and market failures.
Second, by stressing how changes in health such as the global South’s epidemiological
transition have influenced economics and by emphasising the beneficial impact of taxation for
health, it also showed that the relation between economics and global health is not necessarily
unidirectional and detrimental to the latter. In doing so, this article contributed to the recent
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body of work that warns against the inflationary and often unthinking use of neo-liberalism to
explain change (for example, Ferguson, 2009; Collier, 2011). More broadly perhaps, it calls
for researchers to go beyond neoliberal structural adjustment policies and start telling other,
different stories about the economisation of global public health.
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